Chemcon Speciality Chemicals Limited
Chemcon Speciality Chemicals Limited (CHEMCON) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
cscpl.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 |
|---|---|---|---|
| Sales | 55 Cr | 54 Cr | 54 Cr |
| Operating expenses (approx.) | 49 Cr | 46 Cr | 47 Cr |
| EBITDA | 6 Cr | 8 Cr | 7 Cr |
| OPM % | 10.5% | 14.5% | 12.8% |
| Other income | 3 Cr | 4 Cr | 4 Cr |
| Interest | 0.84 Cr | 0.34 Cr | 0.09 Cr |
| Depreciation | 3 Cr | 3 Cr | 3 Cr |
| Profit before tax | 5 Cr | 8 Cr | 8 Cr |
| Tax % | 26.9% | 24.2% | 27.6% |
| Net profit | 4 Cr | 6 Cr | 6 Cr |
| EPS (₹) | ₹1.08 | ₹1.74 | ₹1.57 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 207 Cr | Sign in for TTM |
| Operating expenses (approx.) | 175 Cr | Sign in for TTM |
| EBITDA | 33 Cr | Sign in for TTM |
| OPM % | 15.8% | Sign in for TTM |
| Other income | 14 Cr | Sign in for TTM |
| Interest | 3 Cr | Sign in for TTM |
| Depreciation | 11 Cr | Sign in for TTM |
| Profit before tax | 33 Cr | Sign in for TTM |
| Tax % | 26.2% | Sign in for TTM |
| Net profit | 24 Cr | Sign in for TTM |
| EPS (₹) | ₹6.68 | Sign in for TTM |
| Dividend payout % | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 |
|---|---|
| Equity capital | 37 Cr |
| Reserves | 464 Cr |
| Borrowings | 25 Cr |
| Other liabilities | 29 Cr |
| Total liabilities | 554 Cr |
| Fixed assets (net) | 149 Cr |
| CWIP | 40 Cr |
| Investments | 10 Cr |
| Inventories | 86 Cr |
| Trade receivables | 52 Cr |
| Cash & bank | 7 Cr |
| Other assets | 210 Cr |
| Total assets | 554 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 |
|---|---|
| Cash from operating activity | 41 Cr |
| Cash from investing | -19 Cr |
| Cash from financing | -22 Cr |
| Net cash flow | 0.05 Cr |
| Free cash flow (OCF − Capex) | 31 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 |
|---|---|
| ROCE % | 7.0% |
| ROE % | 4.9% |
| Debtor days | 91 |
| Inventory days | 268 |
| Days payable | 51 |
| Cash conversion cycle | 308 |
| Debt / equity | 0.05 |
| Current ratio | 6.69 |
| Net debt / EBITDA | 0.53 |
Compare with peers
Loading peers…